Cargando…
Faecal Metabolomics in Paediatric Inflammatory Bowel Disease: A Systematic Review
BACKGROUND AND AIMS: Paediatric inflammatory bowel disease [IBD] is characterized by altered immunological and metabolic pathways. Metabolomics may therefore increase pathophysiological understanding and could develop into characterization of biomarkers for diagnosis and IBD treatment response. Howe...
Autores principales: | Jagt, Jasmijn Z, Verburgt, Charlotte M, de Vries, Ralph, de Boer, Nanne K H, Benninga, Marc A, de Jonge, Wouter J, van Limbergen, Johan E, de Meij, Tim G J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683079/ https://www.ncbi.nlm.nih.gov/pubmed/35679608 http://dx.doi.org/10.1093/ecco-jcc/jjac079 |
Ejemplares similares
-
Personalised azithromycin+metronidazole (PAZAZ), in combination with standard induction therapy, to achieve a faecal microbiome community structure and metagenome changes associated with sustained remission in paediatric Crohn’s disease (CD): protocol of a pilot study
por: Verburgt, Charlotte M, et al.
Publicado: (2023) -
Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study
por: Jagt, Jasmijn Z., et al.
Publicado: (2021) -
Safety of Accelerated Infliximab Infusions in Children With Inflammatory Bowel Disease: A Retrospective Cohort Study
por: Jagt, Jasmijn Z., et al.
Publicado: (2023) -
Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control Study
por: Jagt, Jasmijn Z, et al.
Publicado: (2021) -
Nutritional Therapy Strategies in Pediatric Crohn’s Disease
por: Verburgt, Charlotte M., et al.
Publicado: (2021)